Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

X-linked clonality testing: interpretation and limitations.

George L Chen1, Josef T Prchal

  • 1Division of Blood and Marrow Transplant, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA.

Blood
|April 17, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Late Cytomegalovirus Infections After Allogeneic Hematopoietic Cell Transplant.

American journal of hematology·2026
Same author

Reduced relapse in high risk acute myeloid leukemia and myelodysplastic neoplasms with permissive HLA-DPB1 mismatches and post-transplant cyclophosphamide.

Leukemia·2026
Same author

Selinexor plus ruxolitinib in JAK inhibitor-naïve patients with myelofibrosis: a multicenter, open-label, phase 1 study.

Blood advances·2026
Same author

Why JAK2-mutated neutrophils deserve to be on center stage in polycythemia vera.

Annals of hematology·2026
Same author

Ropeginterferon alfa-2b has minimal transplacental passage and breastmilk secretion in pregnant patients with MPN.

Blood advances·2026
Same author

Autosomal Dominant Erythrocytosis Caused by Non-Renal Erythropoietin (EPO) Due to EPO c.-136 G>A Germline Mutation.

American journal of hematology·2026
Same journal

Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

Blood·2026
Same journal

Identifying steroid-refractory aGVHD before it happens.

Blood·2026
Same journal

ELISA-negative HIT: antibody recognition and relevance.

Blood·2026
Same journal

EBV and immunodeficiency: the odd couple drawn to the brain.

Blood·2026
Same journal

A bone to pick with ferric carboxymaltose.

Blood·2026
Same journal

A step toward streamlining HIT diagnosis.

Blood·2026
See all related articles

Detecting clonal cells in hematology is crucial for defining disease states. X-chromosome inactivation patterns (XCIP) offer a phenotypic method to identify these clonal populations, aiding in understanding genetic and autoimmune disorders.

Area of Science:

  • Hematology
  • Genetics
  • Immunology

Background:

  • Clonal cells, genetically identical, are key in hematologic diseases.
  • Clonality detection uses genotypic (somatic mutations) or phenotypic (gene expression) methods.
  • Phenotypic clonality often employs X-chromosome inactivation patterns (XCIP).

Purpose of the Study:

  • To detail the principles and applications of phenotypic clonality detection using XCIP.
  • To explore the role of XCIP in identifying clonal hematopoiesis and its implications.
  • To discuss potential errors and future research directions in clonality assessment.

Main Methods:

  • XCIP relies on distinguishing active from inactive X chromosomes and their parental origin.
  • Detection involves analyzing X-chromosome sequence polymorphisms via protein isoforms, mRNA, or methylation status.

Related Experiment Videos

  • Methods integrate XCIP with genetic clonality testing for comprehensive analysis.

    • Main Results:

    • XCIP identifies clonal populations by analyzing X-chromosome inactivation patterns.
    • Studies suggest progressive X-chromosome skewing in aging hematopoietic cells.
    • XCIP provides insights into X-linked and autoimmune disorder pathophysiology.

    Conclusions:

    • Phenotypic clonality testing via XCIP is a valuable tool in hematology.
    • Understanding X-chromosome inactivation dynamics is crucial for disease insights.
    • Combining XCIP with genetic methods enhances clonal population identification and discovery.